CN101175862A - 诊断膀胱癌的方法 - Google Patents

诊断膀胱癌的方法 Download PDF

Info

Publication number
CN101175862A
CN101175862A CNA2006800115808A CN200680011580A CN101175862A CN 101175862 A CN101175862 A CN 101175862A CN A2006800115808 A CNA2006800115808 A CN A2006800115808A CN 200680011580 A CN200680011580 A CN 200680011580A CN 101175862 A CN101175862 A CN 101175862A
Authority
CN
China
Prior art keywords
polypeptide
seq
bladder cancer
gene
blc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800115808A
Other languages
English (en)
Chinese (zh)
Inventor
中村佑辅
片桐丰雅
中鹤修一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc, University of Tokyo NUC filed Critical Oncotherapy Science Inc
Publication of CN101175862A publication Critical patent/CN101175862A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2006800115808A 2005-02-10 2006-02-09 诊断膀胱癌的方法 Pending CN101175862A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65231805P 2005-02-10 2005-02-10
US60/652,318 2005-02-10
US70322505P 2005-07-27 2005-07-27
US60/703,225 2005-07-27

Publications (1)

Publication Number Publication Date
CN101175862A true CN101175862A (zh) 2008-05-07

Family

ID=36570700

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800115808A Pending CN101175862A (zh) 2005-02-10 2006-02-09 诊断膀胱癌的方法

Country Status (5)

Country Link
US (3) US7998695B2 (enExample)
EP (5) EP2011885B1 (enExample)
JP (2) JP5109131B2 (enExample)
CN (1) CN101175862A (enExample)
WO (1) WO2006085684A2 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102858999A (zh) * 2009-12-01 2013-01-02 简要生物科学有限公司 癌症的分类
CN103033625A (zh) * 2012-12-19 2013-04-10 中国科学院生物物理研究所 一种人膀胱癌细胞化学发光检测试剂盒及其制备方法
CN107400704A (zh) * 2016-05-20 2017-11-28 博尔诚（北京）科技有限公司 一种用于乳腺癌筛查的组合物及其应用
CN110320369A (zh) * 2019-07-31 2019-10-11 天津医科大学第二医院 一种诊断膀胱癌试剂盒
CN111206093A (zh) * 2018-11-21 2020-05-29 立森印迹诊断技术（无锡）有限公司 一种用于检测浸润性膀胱癌的标志物及其应用
CN114854860A (zh) * 2022-05-05 2022-08-05 北京化工大学 一种膀胱癌干细胞生物标志物组及其应用

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668354A2 (en) 2003-09-24 2006-06-14 Oncotherapy Science, Inc. Method of diagnosing breast cancer
CA2862993C (en) * 2004-07-23 2019-01-15 Pacific Edge Biotechnology Ltd. Urine markers for detection of bladder cancer
EP1851543A2 (en) 2005-02-24 2007-11-07 Compugen Ltd. Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
AU2006241235B2 (en) * 2005-04-22 2012-04-05 Eisai, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
TW200741009A (en) * 2005-07-01 2007-11-01 Oncotherapy Science Inc Methods of modulating SMYD3 for treatment of cancer
CN101432303A (zh) * 2006-02-28 2009-05-13 肿瘤疗法科学股份有限公司 利用抗cdh3抗体的效应物功能来损伤细胞的方法
US8673548B2 (en) 2006-08-10 2014-03-18 Oncotherapy Science, Inc. Genes and polypeptides relating to breast cancers
CA2661662A1 (en) * 2006-08-25 2008-02-28 Oncotherapy Science, Inc. Methods of screening for agents that inhibit binding between mphosph1 and prc1
KR101454287B1 (ko) * 2006-10-17 2014-11-04 온코세라피 사이언스 가부시키가이샤 Ｍｐｈｏｓｐｈ1 또는 ｄｅｐｄｃ1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
AU2013200566B2 (en) * 2006-10-17 2014-10-09 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
US20100009920A1 (en) * 2006-12-13 2010-01-14 Yusuke Nakamura Ttk as tumor marker and therapeutic target for lung cancer
RS53362B (sr) 2007-04-05 2014-10-31 Morphotek, Inc. Postupak inhibiranja vezivanja endosijalina na ligande
WO2008152816A1 (en) 2007-06-14 2008-12-18 Oncotherapy Science, Inc. Methods of identifying agents that modulate methylation of vegfr1 by smyd3
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer
WO2009016691A1 (en) * 2007-07-30 2009-02-05 Oncotherapy Science, Inc. Cancer associated gene ly6k
SG183717A1 (en) 2007-08-20 2012-09-27 Oncotherapy Science Inc Foxm1 peptide and medicinal agent comprising the same
UA100127C2 (ru) 2007-08-20 2012-11-26 Онкотерапи Саенс, Инк. Пептид cdh3 и лекарственное средство, содержащее его
AU2008290061B2 (en) * 2007-08-20 2014-01-30 Oncotherapy Science, Inc. CDCA1 peptide and pharmaceutical agent comprising the same
WO2009028580A1 (en) * 2007-08-24 2009-03-05 Oncotherapy Science, Inc. Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
US20120135875A1 (en) * 2008-02-29 2012-05-31 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
WO2009113674A1 (ja) * 2008-03-14 2009-09-17 学校法人北里研究所 膀胱癌の診断
US8652478B2 (en) 2008-06-09 2014-02-18 Oxford Biotherapeutics Ltd. Method for treating cancer by administering antibody to ephrin type-A receptor 7
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
CA2729403A1 (en) 2008-06-30 2010-01-07 Oncotherapy Science, Inc. Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
TWI466680B (zh) 2008-08-01 2015-01-01 Oncotherapy Science Inc Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
TWI543767B (zh) 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
CA2735148A1 (en) * 2008-08-28 2010-03-04 Oncotherapy Science, Inc. Oip5 as a target gene for cancer therapy and diagnosis
EP2362904B1 (en) * 2008-08-28 2016-11-16 Oncotherapy Science, Inc. Method of screening compounds for use in inhibiting depdc1 - znf224 binding
JP5663790B2 (ja) 2008-10-22 2015-02-04 オンコセラピー・サイエンス株式会社 Ｒａｂ６ｋｉｆｌ／ｋｉｆ２０ａエピトープペプチドおよびそれを含むワクチン
US20110301056A1 (en) * 2008-12-12 2011-12-08 Oncotherapy Science, Inc. Nectin-4 for target genes of cancer therapy and diagnosis
GB0823445D0 (en) * 2008-12-23 2009-01-28 Univ Surrey Biomarker
CA2751161C (en) 2008-12-30 2018-10-02 Children's Medical Center Corporation Method of predicting acute appendicitis
TWI469791B (zh) 2009-02-18 2015-01-21 Oncotherapy Science Inc Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
TW201102081A (en) 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
CN102549169B (zh) * 2009-07-24 2016-02-24 吉第克生物技术有限公司 子宫内膜癌的标记物
US20120231472A1 (en) * 2009-11-07 2012-09-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011069014A1 (en) 2009-12-04 2011-06-09 Cedars-Sinai Medical Center Tox3 as a biomarker for breast cancer
GB0922085D0 (en) * 2009-12-17 2010-02-03 Cambridge Entpr Ltd Cancer diagnosis and treatment
ES2701626T3 (es) 2009-12-28 2019-02-25 Oncotherapy Science Inc Anticuerpos anti-CDH3 y sus usos
TWI485245B (zh) 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
TWI538685B (zh) 2010-04-02 2016-06-21 腫瘤療法 科學股份有限公司 Ｅｃｔ２胜肽及含此胜肽之疫苗
EP2380991A1 (en) 2010-04-20 2011-10-26 Universitätsklinikum Hamburg-Eppendorf Method of determining the metastatic potential of a tumor
US20110262921A1 (en) * 2010-04-23 2011-10-27 Sabichi Anita L Test for the Detection of Bladder Cancer
WO2012009382A2 (en) * 2010-07-12 2012-01-19 The Regents Of The University Of Colorado Molecular indicators of bladder cancer prognosis and prediction of treatment response
CN103153063B (zh) 2010-07-30 2016-02-17 肿瘤疗法科学股份有限公司 喹啉衍生物及含有其的melk抑制剂
EP2426216A1 (en) * 2010-09-01 2012-03-07 Institut Gustave Roussy (IGR) Prognostic and/or predictive biomarkers and biological applications thereof
EP2670866A4 (en) * 2011-04-05 2015-09-02 Translational Genomics Res Inst BIOMARKERS AND METHOD OF APPLICATION THEREFOR
WO2012178087A1 (en) * 2011-06-22 2012-12-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of bladder cancer
WO2013018690A1 (ja) 2011-07-29 2013-02-07 国立大学法人徳島大学 Erap1由来ペプチド及びその使用
DK2742133T3 (en) 2011-08-12 2017-12-04 Oncotherapy Science Inc MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THESE
SG10201608552WA (en) 2011-10-28 2016-12-29 Oncotherapy Science Inc Topk Peptides And Vaccines Including The Same
EP2776832A4 (en) * 2011-11-11 2015-06-03 Metabolon Inc BIOMARKER FOR BUBBLE CANCER AND METHOD FOR ITS USE
HUE045359T2 (hu) 2011-12-14 2019-12-30 Univ Texas Kollaterális gén inaktiváló biomarkerek és célsejtek a rákterápiában
SG11201403335WA (en) 2012-01-19 2014-09-26 Oncotherapy Science Inc 1,5-naphthyridine derivatives and melk inhibitors containing the same
WO2013134649A1 (en) * 2012-03-09 2013-09-12 Verastem, Inc. Biomarkers for cancer stem cells and related methods of use
EP2872531A4 (en) 2012-07-10 2016-04-06 Oncotherapy Science Inc LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
JP6259983B2 (ja) 2012-07-10 2018-01-17 オンコセラピー・サイエンス株式会社 Ｔｈ１細胞のＫＩＦ２０Ａエピトープペプチドおよびこれを含有するワクチン
JP6255593B2 (ja) 2012-07-10 2018-01-10 オンコセラピー・サイエンス株式会社 Ｔｈ１細胞のＣＤＣＡ１エピトープペプチドおよびこれを含有するワクチン
KR101942148B1 (ko) 2012-09-27 2019-01-24 추가이 세이야쿠 가부시키가이샤 Ｆｇｆｒ３ 융합 유전자 및 그것을 표적으로 하는 의약
DE102012021222B4 (de) * 2012-10-27 2015-02-05 Forschungszentrum Jülich GmbH Verfahren zur Herstellung einer nanoporösen Schicht auf einem Substrat
WO2014138396A1 (en) * 2013-03-06 2014-09-12 Cepheid Methods of detecting bladder cancer
EP3696283B1 (en) * 2013-03-08 2022-02-16 MDxHealth Research B.V. Molecular markers in bladder cancer
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Ｋｎｔｃ２胜肽及含此胜肽之疫苗
KR101573467B1 (ko) * 2013-04-10 2015-12-01 (주)지노믹트리 방광암 특이적 후성유전적 마커 유전자를 이용한 방광암의 검출방법
CA2928901A1 (en) * 2013-11-04 2015-05-07 The University Of British Columbia Cancer biomarkers and classifiers and uses thereof
SG11201609707WA (en) 2014-07-01 2017-01-27 Pfizer Bispecific heterodimeric diabodies and uses thereof
CN107074908B (zh) 2014-08-04 2021-10-15 肿瘤疗法科学股份有限公司 Cdca1衍生的肽和含有它们的疫苗
SG11201700838VA (en) 2014-08-04 2017-03-30 Oncotherapy Science Inc Urlc10-derived peptide and vaccine containing same
WO2016115089A1 (en) 2015-01-12 2016-07-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Blood biomarkers for respiratory infections
WO2016154493A1 (en) * 2015-03-24 2016-09-29 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for multi-scale, annotation-independent detection of functionally-diverse units of recurrent genomic alteration
GB201511191D0 (en) * 2015-06-25 2015-08-12 Immatics Biotechnologies Gmbh T-cell epitopes for the immunotherapy of myeloma
CN112961213A (zh) 2015-08-12 2021-06-15 肿瘤疗法科学股份有限公司 Depdc1衍生的肽和包含它们的疫苗
CA3000808A1 (en) 2015-10-08 2017-04-13 Sachiko YAMASHITA Mphosph1-derived peptide, and vaccine including same
BR112018005581A2 (pt) 2015-10-08 2018-10-16 Oncotherapy Science, Inc. peptídeo derivado de foxm1 e vacina incluindo o mesmo
US10635909B2 (en) * 2015-12-30 2020-04-28 Texas Instruments Incorporated Vehicle control with efficient iterative triangulation
US10669310B2 (en) 2016-01-19 2020-06-02 Tokushima University Peptide for cancer treatment and pharmaceutical composition containing same
CN105886629B (zh) * 2016-04-29 2019-09-27 北京泱深生物信息技术有限公司 分子标志物在诊治食管鳞癌中的应用
JP6769596B2 (ja) * 2016-05-30 2020-10-14 学校法人北里研究所 膀胱癌診断薬及び生体試料の判定方法
RU2756982C2 (ru) 2016-08-31 2021-10-07 Онкотерапи Сайенс, Инк. Моноклональное антитело против melk и его использование
TWI762516B (zh) 2016-10-06 2022-05-01 日商腫瘤療法 科學股份有限公司 針對ｆｚｄ１０之單株抗體及其用途
NL2020004B1 (en) 2016-12-09 2018-07-02 Ary Flohil Jacob Treatment of diffuse intrinsic pontine glioma
WO2019017384A1 (ja) 2017-07-19 2019-01-24 国立大学法人徳島大学 ペプチド誘導体及びそれを含む医薬組成物
CN110018309B (zh) * 2018-01-08 2023-07-04 成都市第三人民医院 通过蛋白标志物判断结直肠癌预后的试剂盒
KR102171774B1 (ko) * 2018-06-04 2020-10-29 울산대학교 산학협력단 인산화된 tfcp2l1을 포함하는 고형암 예후 예측용 바이오마커 조성물 및 이의 용도
CN112739832B (zh) * 2018-06-06 2024-06-04 外来体诊断公司 用于开发尿液生物标志物和用于检测膀胱癌的方法
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
US20210379148A1 (en) * 2020-05-12 2021-12-09 University Of Maryland, Baltimore Regulating muscle physiology and energy metabolism using crym
CN115501340B (zh) * 2021-06-07 2024-04-12 中山大学附属第三医院（中山大学肝脏病医院） CircPIAS1作为靶点在制备肝癌诊断试剂或治疗药物中的用途
CN113322523B (zh) * 2021-06-17 2024-03-19 翌圣生物科技(上海)股份有限公司 Rna快速建库方法及其应用
CN116121373A (zh) * 2022-09-14 2023-05-16 中山大学孙逸仙纪念医院 Etv4及其表达产物在制备诊断和治疗膀胱癌药物中的应用
WO2024192018A1 (en) * 2023-03-12 2024-09-19 Novelna Inc. Bladder cancer detection proteins and methods of use thereof
CN120064671B (zh) * 2025-04-29 2025-07-29 吉林大学 用于检测幼儿唾液prb1含量的组合物及应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239102A3 (en) 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Process for the formation of human-human hybridoma
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
JP2938569B2 (ja) 1990-08-29 1999-08-23 ジェンファーム インターナショナル，インコーポレイティド 異種免疫グロブリンを作る方法及びトランスジェニックマウス
SG48760A1 (en) 1992-07-24 2003-03-18 Abgenix Inc Generation of xenogenetic antibodies
CA2161351C (en) 1993-04-26 2010-12-21 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
DE69637481T2 (de) 1995-04-27 2009-04-09 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
EP0823941A4 (en) 1995-04-28 2001-09-19 Abgenix Inc HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
US7001999B1 (en) * 1998-04-15 2006-02-21 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor
US20020103360A1 (en) 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
IL148798A0 (en) 1999-09-27 2002-09-12 Quark Biotech Inc Sequences characteristic of bladder cancer
WO2001053312A1 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001231025A1 (en) * 2000-01-20 2001-07-31 Cedars-Sinai Medical Center Method of detecting neoplastic, hyperplastic, cytologically dysplastic and/or premalignant cellular growth or proliferation
CA2425827A1 (en) 2000-10-12 2002-04-18 Hyseq, Inc. Novel nucleic acids and polypeptides
US20030157561A1 (en) 2001-11-19 2003-08-21 Kolkman Joost A. Combinatorial libraries of monomer domains
US20040076955A1 (en) * 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
US7494646B2 (en) * 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
WO2003083074A2 (en) * 2002-03-28 2003-10-09 Idec Pharmaceuticals Corporation Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
DE602004032114D1 (de) 2003-02-28 2011-05-19 Oncotherapy Science Inc Rna-interferenz für das gen znfn3a1 als verfahren zur hemmung des wachstums von krebszellen
EP2343384A3 (en) 2004-03-23 2012-01-04 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancer
KR101454287B1 (ko) 2006-10-17 2014-11-04 온코세라피 사이언스 가부시키가이샤 Ｍｐｈｏｓｐｈ1 또는 ｄｅｐｄｃ1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
WO2008152816A1 (en) * 2007-06-14 2008-12-18 Oncotherapy Science, Inc. Methods of identifying agents that modulate methylation of vegfr1 by smyd3

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102858999A (zh) * 2009-12-01 2013-01-02 简要生物科学有限公司 癌症的分类
CN103033625A (zh) * 2012-12-19 2013-04-10 中国科学院生物物理研究所 一种人膀胱癌细胞化学发光检测试剂盒及其制备方法
CN103033625B (zh) * 2012-12-19 2014-12-24 中国科学院生物物理研究所 一种人膀胱癌细胞化学发光检测试剂盒及其制备方法
CN107400704A (zh) * 2016-05-20 2017-11-28 博尔诚（北京）科技有限公司 一种用于乳腺癌筛查的组合物及其应用
CN111206093A (zh) * 2018-11-21 2020-05-29 立森印迹诊断技术（无锡）有限公司 一种用于检测浸润性膀胱癌的标志物及其应用
CN110320369A (zh) * 2019-07-31 2019-10-11 天津医科大学第二医院 一种诊断膀胱癌试剂盒
CN110320369B (zh) * 2019-07-31 2022-05-17 天津医科大学第二医院 一种诊断膀胱癌试剂盒
CN114854860A (zh) * 2022-05-05 2022-08-05 北京化工大学 一种膀胱癌干细胞生物标志物组及其应用

Also Published As

Publication number Publication date
JP2012135301A (ja) 2012-07-19
US20120014996A1 (en) 2012-01-19
WO2006085684A2 (en) 2006-08-17
EP1856278A2 (en) 2007-11-21
EP2011885A3 (en) 2009-06-24
US8685641B2 (en) 2014-04-01
US20090175844A1 (en) 2009-07-09
EP2011885B1 (en) 2015-04-22
EP2011885A2 (en) 2009-01-07
US7998695B2 (en) 2011-08-16
EP2292796A1 (en) 2011-03-09
US20130011933A1 (en) 2013-01-10
JP2008532477A (ja) 2008-08-21
EP2311983A1 (en) 2011-04-20
JP5109131B2 (ja) 2012-12-26
EP2295601A1 (en) 2011-03-16
WO2006085684A3 (en) 2007-03-29
WO2006085684A9 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
JP5109131B2 (ja) 膀胱癌を診断する方法
JP4579246B2 (ja) 乳癌を診断する方法
WO2011096210A1 (en) Prmt1 and prmt6 for target genes of cancer therapy and diagnosis
JP2006517783A (ja) ヒト骨髄性白血病に関連する遺伝子およびポリペプチド
US7521205B2 (en) Genes and polypeptides relating to prostate cancers
JP2009502112A (ja) 腎細胞癌を診断および処置するための方法
EP1786925B1 (en) Genes and polypeptides relating to breast cancers
WO2012090479A1 (en) Mcm7 as a target gene for cancer therapy and diagnosis
CN101278060B (zh) 作为乳腺癌标志的基因galnt6和针对基因galnt6的小干扰rna
US8067153B2 (en) Genes and polypeptides relating to prostate cancers
JP2012501166A (ja) 乳癌関連遺伝子ｒｑｃｄ１
JP2013502203A (ja) 肺癌および食道癌関連遺伝子ａｄａｍｔｓ１８
JP2009505631A (ja) 癌関連遺伝子ｒａｓｇｅｆ１ａ
JP2010500004A (ja) 前立腺癌関連遺伝子ｓｔｙｋ１
JP2008505601A (ja) 前立腺癌に関連した遺伝子及びポリペプチド
WO2011024428A1 (en) Breast cancer related gene c12orf32

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: ONCOTHERAPY SCIENCE INC.

Free format text: FORMER OWNER: ONCOTHERAPY SCIENCE INC.; APPLICANT

Effective date: 20080801

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20080801

Address after: Kanagawa

Applicant after: Oncotherapy Science Inc.

Address before: Kanagawa

Applicant before: Cancer therapy science Limited by Share Ltd

Co-applicant before: Univ Tokyo

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20080507